Appointments Underscore Sabin Vaccine Institute's Cancer Vaccine Efforts

Sabin's picture Submitted by Sabin on

NEW CANAAN, CT, January 30, 2006—The Board of Trustees of the Albert B. Sabin Vaccine Institute (Sabin) announced personnel changes made to strengthen the Institute’s efforts in the area of cancer vaccines. At a January 12 meeting in New York, the Board elected Axel Hoos, MD, PhD, as a trustee and approved the appointment of Robert Allen, MD, as vice president for cancer programs.

Sabin
Source URL: 
Appointments Underscore Sabin Vaccine Institute's Cancer Vaccine Efforts

Controlling Neglected Tropical Diseases Will Boost Fight against HIV, TB, and Malaria

Sabin's picture Submitted by Sabin on

Achieving success in the global fight against the "big three" diseases-HIV/AIDS, tuberculosis and malaria, which together account for 5.6 million deaths a year-may well require a concurrent attack on the world's most neglected tropical diseases, says a team of researchers in the international open access journal PLoS Medicine.

Earth Institute
Source URL: 
Controlling Neglected Tropical Diseases Will Boost Fight against HIV, TB, and Malaria

Sabin Receives $150,000 Grant to Strategize for Introduction and Sustainable Use of Vaccines in Developing Countries

Sabin's picture Submitted by Sabin on

WASHINGTON, D.C., Sept. 7, 2005 – The Albert B. Sabin Vaccine Institute (Sabin), a leader in promoting the development and use of safe and effective vaccines to prevent disease, announced receipt of a grant of $150,000 from the Bill & Melinda Gates Foundation for the sponsorship of a vaccine policy colloquium to be held at Cold Spring Harbor, Long Island, New York, October 19-21, 2005.

Sabin
Source URL: 
Sabin Receives $150,000 Grant to Strategize for Introduction and Sustainable Use of Vaccines in Developing Countries

Seventh Sabin Vaccine Institute Colloquium on Cancer Vaccines and Immunotherapy

Sabin's picture Submitted by Sabin on

NEW CANAAN, CT—Thirty-five leading cancer vaccine researchers met to consider medical progress in treating cancer with vaccines during a three-day meeting convened by New Canaan’s Sabin Vaccine Institute (Sabin) held this past June.

Sabin
Source URL: 
Seventh Sabin Vaccine Institute Colloquium on Cancer Vaccines and Immunotherapy

Sabin Vaccine Institute Honors Scientific Innovators and Newsmaker at Annual Benefit

Sabin's picture Submitted by Sabin on

NEW CANAAN, CT, JUNE 29, 2005 —The Sabin Vaccine Institute will recognize extraordinary contributors to disease research and healthcare innovations at its black-tie gala beginning at 6:30 p.m. on June 29, 2005 at the University Club in New York City.

Sabin
Source URL: 
Sabin Vaccine Institute Honors Scientific Innovators and Newsmaker at Annual Benefit

Vaccine Developer Albert Z. Kapikian, MD, Awarded the Sabin Gold Medal

Sabin's picture Submitted by Sabin on

NEW CANAAN, CT— Albert Z. Kapikian, MD, physician, medical pioneer and viral diseases researcher, received the prestigious Albert B. Sabin Gold Medal at a ceremony on May 10, 2005. Kapikian is the 13th recipient of this recognition, awarded annually by the Sabin Vaccine Institute to honor achievements by vaccinologists and infectious disease experts.

Sabin
Source URL: 
Vaccine Developer Albert Z. Kapikian, MD, Awarded the Sabin Gold Medal

Pages